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In order to further investigate host-parasite interactions in onchocerciasis, a major Onchocerca 
volvulus histidine rich antigen termed OvL3.C1 was isolated from an O. volvulus cDNA library using 
antibodies from putatively immune subjects living in onchocerciasis endemic communities in 
Cameroon. Analysis of its sequences predicted the protein to be helix-rich with a single transmembrane 
region. Recombinant OvL3.C1 antigen induced from pBAD-TOPO/Thio vector in Escherichia coli was 
purified as inclusion bodies and further by a combination of Ni2+ chelate chromatography and electro-
elution.   Anti-OvL3.C1 immunoglobulin G (IgG) subclass levels were assessed by ELISA in 15 pairs and 
18 pairs of selected and cross-matched infected and putatively immune subjects from Cameroon and 
Ecuador, respectively. IgG3 and IgG4 levels were shown to be significantly higher in putatively immune 
(immune protected) subjects. A higher IgG3 level in endemic normal subjects is implicated in parasite 
killing and the development of the putative immune status while IgG4 has been shown to block 
onchocercal pathology. OvL3.C1 is a dominant antigen in onchocerciasis which elicits strong 
responses in subjects expose to both African and South American forms of onchocerciasis. It is 
therefore an important player in mechanisms of resistance or allergy attenuation in onchocerciasis.  
 





Onchocerciasis has adverse impact on the health and 
quality of life of the infected population. The commonly 
used control strategies involving vector control and 
chemotherapy have limitations; they are prolonged, 
expensive and associated with numerous relapses 
(Molyneaux and Davies, 1997). Thus complementary 
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ed. However, the development of a vaccine against 
helminthic parasites like Onchocerca volvulus is 
hampered by the complexity of antigenic profiles and the 
parasites’ ability to evade or suppress the immune 
system (Sher, 1988). 
Immunoepidemiological data collected over the past 20 
years provide compelling evidence that humans can 
acquire protective immunity against O. volvulus infection 
(Selkirk et al., 1992; Abraham et al., 2002). However, 
many gaps remain in our understanding of the 
relationships linking this acquired resistance to O. 
volvulus and antigens potentially of use as vaccines. 
Antibody and cellular responses  of  selected  and  cross 




matched infected and endemic normal subjects have 
been reported in several endemic regions and in 
Cameroon to a potentially immunoprotective antigen 
Ov47 (Ward et al., 1988; Elson et al., 1994; Ghogomu et 
al., 2002; Titanji et al., 2002). To further identify antigens 
involve in protective immunity against O. volvulus, sera 
from resistant individuals living in endemic areas 
(putatively immune subjects) were used to screen a 
cDNA library of the infective stage of the parasite. Here 
we report on the identification, cloning and serological 
characterisation of a recombinant antigen termed 
OvL3.C1 (Genbank accession number, AJ272105) as an 
additional dominant marker of immune mechanisms in 
human onchocerciasis.  
 
 
MATERIALS AND METHODS 
 
Subjects and sera 
 
Sera from Cameroon and Ecuador were used. The study area in 
Cameroon was the onchocerciasis endemic area of Mbonge that 
had been previously described (Ghogomu et al., 2002; Titanji et al., 
2002). The study area and subjects from Ecuador have been 
extensively described by Elson et al. (1994). Subjects included in 
the study were either putatively immune to or infected with O. 
volvulus. Putatively immune subjects from Cameroon were endemic 
residents who showed neither skin microfilaria nor onchocercal 
stigmata after a longitudinal survey of 1300 inhabitants over 36 
months. They also must have lived in the endemic zone for at least 
10 years. Infected subjects were those who had all signs of 
onchocercal pathology and skin microfilariae. Sera from 15 
putatively immune subjects and their age/sex cross matched 
onchocerciasis infected pairs were selected, pooled separately and 
employed for comparative immunoscreening of O. volvulus cDNA 
library. Before use, fifty microlitres of each pool was thoroughly 
mixed and depleted of Escherichia coli antibodies using E. coli total 
cell lysate. Briefly, 2.5% glutaraldehyde solution was added 
dropwise to 5 mg of E. coli cleared lysate to form an 
immunosorbent gel. Pooled sera were diluted 1:10 in phosphate 
buffered saline (PBS) containing 3% bovine serum albumin (BSA) 
and mixed with the antigen gel. Mixtures were rocked gently for 1 h 
and centrifuged. Supernatants were collected and repeatedly 
depleted of E. coli antibodies using fresh immunosorbent until anti-
E. coli antibodies were undetectable by ELISA.  
From a set of 43 onchocerciasis infected and 40 putatively 
immune sera from Esmeralda Province in Ecuador that were 
donated by Prof. Jan Bradley (Nottingham University), 18 pairs of 
age and sex cross-matched infected and putatively immune 
subjects were selected for comparison with a similar class of 
subjects from Cameroon.  
 
 
Screening of O. volvulus infective stage (L3) cDNA library 
 
An expression library constructed in Lambda unizap using mRNA 
from infective larvae (L3) of O. volvulus was kindly donated by Prof 
Steven Williams (Smiths College Massachusetts, USA). The library 
had a titre of 108 to 1011 plaque forming units/ml. Screening was 
carried out using the Clontech kit following manufacturers 
instructions. After probing of blocked nitrocellulose filters with 
absorbed antisera, unbound antibodies were washed off with three 
changes of PBS containing 0.05% Tween-20. Filters were then 
reacted with rabbit-antihuman IgG followed by biotinylated goat 
antirabbit IgG (Sigma). Plaques with bound antibodies were 





substrate solution, 4-chloro-1-naphtol. Recombinant  pBluescript-
SK (+) was excised and extracted from plaques by IgG from 
putatively immune serum pool and sent for custom sequencing 
(MWG-Biotech, Germany).   
 
 
Preparation of expression construct  
 
Primers specific to the open reading frame of OvL3.C1 and Taq 
DNA polymerise were used to amplify the gene from a pBluescript 
SK (+) vector by PCR. The Primers were 5’ primer: 5’- 
ATGCAGATGCAGATGGTTGT-3’ and 3’ primer: 5’- 
GAATTTTCCCAGCACGTGCT-3’. The PCR was carried out on a 
Gradient Master Cycler (Eppendorf) programmed as follows: pre-
denaturation at 94°C for 4 min, denaturation at 94°C for 1 min, 
annealing at 50°C for 1 min, elongation at 72°C for 2 min, with a 
final elongation at 72°C until 10 min and incubation at 4°C until 
stop. PCR products were analysed on a 1.5% agarose gel ran at 70 
V for 1 h and viewed briefly on a UV transilluminator. 
OvL3.C1 amplicons were cut out and purified from agarose gel 
using Sephaglass band prep Kit (Pharmacia). These were sub-
cloned into the pBAD-TOPO-THIO vector (Invitrogen) in a reaction 
mixture containing 3 µL of fresh PCR product, 1 µL of 100 mM NaCl 
solution, 1 µL of sterile water and 1 µL of TOPO vector. Following 5 
min of incubation on ice, 2 µL of cloning reaction were used directly 
to transform competent Top10 cells (Invitrogen). Recombinants 




Expression and purification of OvL3.C1 
 
Prior to preparative purification, 20 mL cultures were set up from 
single isolated recombinant colonies and grown to saturation 
overnight. Sub-cultures of the overnight cultures were grown to an 
optical density of 0.6 at 600 nm before induction for 5 h with 0.02% 
arabinose. Following analysis on SDS-PAGE, positive cultures were 
processed for purification of recombinant proteins by metal-chelate 
chromatography on Ni2+-sepharose columns (Pharmacia) and then 
by electro-elution.  
Proteins from over expressed cultures were prepurified as 
inclusion bodies prior to electro-elution according to the protocol 
described in Sambrook et al. (1989). Following cell lysis, treatment 
of lysate with 1 µg/mL of Dnase and Rnase each and then 
centrifugation, the pellet (inclusion bodies) was washed thrice in 
PBS (supplemented with 20 mM MgCl2, 25% sucrose, 5 mM EDTA, 
1% Trixton-X-100). It was then suspended in 1 mL of 50 mM Tris-
HCl, pH 8 containing 5 M guanidinium hydrochloride, and briefly 
vortexed vigorously to facilitate the solubilization of the aggregated 
proteins. The resultant suspension was incubated on ice for 1 h, 
centrifuged, added to renaturation buffer  (50 mM Tris-HCl, pH 8, 
20% glycerol, 1 mM DTT), and stirred gently at 4°C overnight to 
renature the proteins. The following day, the supernatant was 
clarified by centrifugation at 12,000 rpm for 30 min at 4°C, analysed 
by SDS-PAGE and stored at –20°C until further purification by 





Computer analyses of the DNA and protein sequences were done 
using bioinformatics softwares available on the World Wide Web. 
The amino acid and DNA sequences of the antigen were used to 
query the nucleic acid databank of nematodes in Wormbase, the 
general nucleic acid databank of the National Center for 
Biotechnological Information (NCBI) and European Molecular 
Biology Laboratory (EMBL) web sites (Wheeler et al., 2004). 
Following translated blast (tBlastx) based on the Blossum62 
algorithm, sequences showing more than 30% homology to the 
amino acid and nucleic acid sequences of the clone were selected 
as putative homologues. Primary structures were compared by























Figure 1. Predicted primary and secondary structures of OvL3.C1. AA: amino acid sequence. PROF_sec: PROF predicted 
secondary structure: H=helix, E=extended (sheet), blank=other (loop). PROF = Profile network prediction heidelberg. Rel_sec: 
reliability index for profsec prediction (0=low to 9=high). P_3: PROF predicted relative solvent accessibility (acc) in 3 states: b = 0-




multiple sequence alignments using ClustalW. Conserved regions 
within homologues were used to pick out putative functional 




Western blot analysis   
 
For SDS-PAGE, O. volvulus, O. gutturosa, O. ochengi adult and O. 
volvulus microfilariae antigens were solubilised in sample buffer as 
described by Lucius et al. (1988). Proteins were separated on a 
12.5% uniform SDS-polyacrylamide gel. Western blot procedures 
were essentially as described by Towbin et al. (1979).  
To identify OvL3.C1 parent proteins, anti-OvL3.C1 antibodies 
were plaque purified and used to probe blots. Briefly, 10 mM 
impregnated nitrocellulose filters overlaid on XL-1 Blue OvL3.C1 
plaques were lifted, washed in Tris buffered saline (TBS) and 
blocked with 0.2% BSA. They were then incubated overnight at 4°C 
with putatively immune serum pool previously depleted of E. coli 
antibodies as described above. Bound anti-OvL3.C1 antibodies 
were eluted using 3 mL of glycine-HCl at pH 2.5 and neutralized 
with 1 M Tris containing 1 mg/mL BSA. These antibodies were used 
to probe Onchocerca protein blots in standard immunoassay. 
Immune complexes were detected using 0.25% (w/v) 
diaminobenzidene (DAB) peroxidase substrate. Development 
reactions were stopped by washing strips abundantly in distilled 
water. All blots were stored in the dark prior to photography or 
scanning for permanent record. 
 
 
Enzyme-linked immunosorbent assays 
 
Standard micro well enzyme linked immunosorbent assay (ELISA) 
was performed using purified recombinant proteins and total O. 
volvulus adult worm antigens (Ghogomu et al., 2002). Optimal 
eagent dilutions and incubation times were determined by chequer-
board titration. Indirect ELISA was used to separately determine 
parasite specific IgE, IgG1, IgG2, IgG3 and IgG4 antibodies present 
in individual patient, putatively immune and European control sera. 
Often 50 µL of 5 µg/ml recombinant protein or 2 µg/ml of crude 
proteins in 50 mM carbonate buffer were added to each well of a 96 
well flat bottom Immulon microtitre plate (Dynex Technologies) and 
incubated overnight at 4°C and then for 1 h at 37°C with 5% non-fat 
milk in PBST (NFM) to block unbound sites. They were probed with 
sera diluted 1:100 for the detection of IgG subtypes and then 
incubated overnight at 4°C. Secondary antibodies were mouse anti-
human monoclonal IgGs (Sigma). The conjugate was HRP-goat-
antimouse immunoglobulins (Biorad) (1:5000) and development 
was with o-phenylene diamine (Sigma) in citrate buffer containing 
0.02% hydrogen peroxide by incubating for 30 min in the dark. 
Reactions were stopped with 25 µL of 3M HCl and optical densities 





Statistical analysis of antibody levels between putatively immune 
and infected subjetcts, as reflected by their optical densities 
obtained in ELISA, were done using the Microsoft Excel package 
and the Number cruncher comprehensive statistic software (NCSS) 
including the power analysis and sample size software for NCSS 
(PASS). Group means, medians and standard deviations of optical 
densities were analysed by T-tests. Non-parametric analyses of two 
samples included the use of Mann-Whitney U or Wilcoxon Rank-
Sum tests for difference in Medians and Kolmogorov-Smirnov Test 
for different distributions. Decisions on significance of differences 
between two groups were at 95% confidence interval (p<0.05) and 





Cloning and expression of OvL3.C1 genes in 
pbad/Thio TOPO vector  
 
Using specific primers, the 288 bp open reading frames 
of OvL3.C1 was amplified from their lambda-zap isolates 
and from pbl subclone (Figure 3). Induction of 
recombinant protein from TOPO-pBAD-thio vector in 
Top10 E. coli bacteria (invitrogen) was strongly controlled 
and the 28 kda OvL3.C1-thioredoxine His-tagged fusion 
protein could only be visible after induction with 0.02% of 
arabinose (Figure 4a). OvL3.C1 fusion protein formed 
inclusion bodies upon optimum expression and remained 
insoluble in 100 mm phosphate buffer at pH 7.4. Proteins 
could be solubilised by lysing cells with phosphate buffer 
supplemented with 6 M urea or 4 M guanidine 
hydrochloride, 2% Trixton-x-100, 2% Tween-20, 10 mM

























Figure 2. Transmembrane helix prediction for OvL3.C1. Plot of probability of location of secondary folds and 
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Figure 3. Subcloning of OvL3.C1. Agarose gel electropho-
regrams of OvL3.C1-specific PCR on O. volvulus L3 cDNA (L3), 
pBL-OvL3.C1 (1, 2); OvL3.C1 colony PCR on OvL3-Topo-




mercaptoethanol and 20% glycerol. OvL3.C1 bound onto 
Ni2+-sepharose column eluted at 2 M imidazole with a 
purity of about 75%.  Inclusion bodies were completely 
soluble only in 8 M urea or 4 M guanidine-HCl (Figure 
4b). Highly homogeneous protein (>95%) could be 
purified by electroelution of inclusion body preparations 
separated by SDS-PAGE (Figure 4c). 
 
Characterisation of native OvL3.C1 antigens 
 
Blots of Onchocerca worm antigens extracted with buffer 
containing 2-mercaptoethanol and SDS revealed bands 
of varying sizes upon reaction with plaque purified 
OvL3.C1-specific antibodies (Figure 5). O. ochengi adult 
females, O. volvulus adult females and microfilariae 
showed reactive bands of 46000 and 94000 while there 
was a strong reaction with a 32000 band from O. 





The OvL3.C1 isolated cDNA had six open reading frames 
(ORFs). The longest complete ORF translates for a 95 
amino acid long histidine-rich protein. This frame is made 
of 14.7% histidine mainly from residue 72 to 95 at the C-
terminus of the protein. Blast analysis of the OvL3.C1 
sequence revealed 54% homology to a hypothetical 
protein from Plasmodium yoelii yoelii and 56% homology 
to a mouse guanine insertion enzyme, tRNA guanine 
transglycosylase (TGUT).  
Secondary structure predictions of the deduced 
aminoacid sequence using PROF and PHD predictive 
algorithms revealed an ‘all-alpha’ molecule with 66.32% 
alpha helices and 33.68% loops (Figure 1). A continuous 
helical stretch from residues 39 to 56 is predicted to have 
a high probability of being a transmembrane region with 
the histidine rich c-terminus tail located to the outside of 
the membrane (Figure 2). A single  putative  N-glycosyla- 
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Figure 4. Expression and purification of OvL3.C1 recombinant fusion proteins. (a) SDS-PAGE electrophoregrams of 
time dependent expression of OvL3.C1-Thio pre-induced (pi) and induced (0.5 – 4 h) and overnight (ON). (b) 
Purification of ovL3.C1 inclusion bodies; washes (b1 - b4) and resolubilised inclusion bodies (IBL3). (c) Electroelution 




                                                













Figure 5. Western blot pattern of OvL3C1 parent proteins. Blots 
of SDS-PAGE separated O. ochengi adult females (1), O. 
guttorosa (2), O. volvulus adult females (3) and O. volvulus 
microfilarial (4) protein extracts were probed with plaque purified 
antibodies from endemic normal serum pool used for 
immunocreeening and selection. Mr indicates the molecular 




tion signal defined by the consensus sequence NFSI is 
located from residues 68 to 71.  
 
 
IgG isotypic responses of onchocerciasis endemic 
subjects to OvL3.C1 
 
The anti-OvL3.C1 IgG1, IgG2, IgG3 and IgG4 subclass 
responses were investigated using two groups of 15 pairs 
and 18 pairs of  matched infected (INF) and putatively im- 
mune individuals from Cameroon and Ecuador, 
respectively. Sera from uninfected inhabitants of 
nonendemic towns in Cameroon and Europeans (NES) 
who have never visited Africa were used as controls. 
Sera from onchocerciasis endemic regions showed a 
variable degree of IgG responses to OvL3.C1 with mean 
values significantly higher than those of the uninfected 
groups. Particularly, the mean OD value of IgG3 antibody 
responses of endemic normal subjects (putatively 
immune subjects) against OvL3.C1 was higher than 
those of the patients from Cameroon (Figure 6a). 
Endemic normal subjects tend to have a higher IgG4 
response to the recombinant antigen though OD values 
were not significantly different from those of infected 
subjects (p<0.05) (Figure 6b). However, putatively 
immune subjects from Ecuador had higher IgG4 levels 
than for infected (Figure 6d) unlike for IgG3 (p<0.05) 
(Figure 6c). IgG1 and IgG2 against the recombinant 
protein did not show any statistical difference between 
putatively immune subjects and INF in both the 





Lack of animal models and parasite material are major 
impediments to the knowledge of onchocerca biology that 
may lead to the development of novel control tools 
against onchocerciasis. To contribute to knowledge on 
onchocerciasis, we employed recombinant DNA techno-
logy to isolate, express and characterize antigens 
associated with O. volvulus. Herein, we describe an anti 
gen clone (OvL3.C1: AJ272105) of O. volvulus that is 
preferentially recognized by exposed but apparently 
healthy subjects (putatively immune) from an 
onchocerciasis endemic zone of Cameroon. As the 
subjects had no onchocercal lesions despite long term 
residence (exceeding 10 years),  they were deemed to be 








































































Figure 6. Anti-OvL3.C1 IgG3 and IgG4 responses of endemic normal subjects (EN) and infected (INF) 
subjects from Cameroon and from Ecuador. Normal European sera (NES) were from European adults 




resistant to infection. Thus isolation of OvL3.C1 cDNA 
from O. volvulus infective larva cDNA library based on its 
preferential recognition by antibodies from these 
putatively immune subjects indicated that the antigen 
may be involve in resistance mechanisms in 
onchocerciasis (Titanji et al., 2002). To better understand 
the nature of the antigen, further analysis of the amino 
acid sequence was done using web based sequence 
analysis tools (Rost, 1996; 2000; Apweiler et al., 2000; 
Wheeler et al., 2004). The recombinant protein was also 
expressed in E. coli bacteria, purified and used to 
analyse its reactivity with antibodies in paired infected 
and putatively immune endemic subjects.  
The isolated OvL3.C1 cDNA translates into a major 95 
amino acid histidine rich protein and five other open 
reading frames. Further sequence analysis revealed the 
95 amino acid protein to be related to histidine rich 
protein family particularly from Plasmodium yoelli and 
mouse mitochondrial tRNA-ribosyltransferase. Despite 
this homology with a mitochondrial protein, the presence 
of a transmembrane sequence (Figure 1) and an N-
glycosylation site suggest that the protein may 
nevertheless be deployed on parasite surface and 
available for immune recognition. Given its reaction with 
antibodies from potentially protected individuals, it may 
belong to the group of ‘vital molecules’ important for 
parasite survival that can be targeted for vaccine 
production or whose pathways may serve as novel 
targets for rational drug and vaccine design against 





TOPO-pBAD contruct expressed a 28 kda insoluble 
recombinant fusion protein with thioredoxine in E. coli. 
Purification could therefore be achieved by first 
solubilising inclusion bodies with detergents followed by 
electroelution (Figure 4).   
To confirm the parasite origin of OvL3.C1, plaque purified 
OvL3.C1 specific antibodies were used to blot protein 
extracts from Onhocerca spp. microfilariae and adult 
worm antigen extracts. Recognition of protein bands from 
32 to 94 kda in both O. volvulus and related nematodes 
O. ochengi and O gutturosa, suggests that the isolated 
clone may be part of a larger dominant antigen, which 
may present additional epitopes common to onchocerca 
spp. (Titanji et al., 2002). It is also probable that the 
difference in native antigen size may have been due to 
sequence divergence between the species. As shown for 
a Trypanosome brucei antigen by Nolan et al. (1997), it is 
possible that posttranslational modification OvL3.C1 by 
N-glycosylation may also have accounted for the 
dramatic increase in the apparent molecular weight of the 
native proteins on SDS-PAGE gels. The occurrence of 
the antigen in different Onchocerca species and in stages 
other than the L3 further underpins the dominance of the 
antigen in host parasite interplay in onchocerciasis.  
In an attempt to further elucidate the association of 
OvL3.C1 to immunity, we compared the IgG reactivities 
of selected and characterised putatively immune and 
infected individuals in Cameroon and Ecuador (Ghogomu 
et al., 2002; Elson et al., 1994). We found a high degree 
of variability in the IgG antibody reactivities of endemic 
subjects to OvL3.C1 recombinant protein. Particularly, 
the recombinant antigen reacted with IgG3 and IgG4 
antibodies in both patients and putatively immune people, 
suggesting that serological responses of putatively 
immune subjects compared to patients in onchocerciasis 
is not always distinctive. However, the proportions of high 
and low respondents to IgG3 and IgG4 subtypes varied 
among patients and putatively immune subjects. In 
Cameroon, it was found that the predominant isotype 
elicited in putatively immune subjects was IgG3, while 
patients showed a tendency to have higher levels of IgG4 
against the recombinant (Figure 6a). IgG3 responses in 
putatively immune people had been shown to be 
important in resistance mechanisms in onchocerciasis 
(Boyer et al., 1991; Ottessen, 1995; Meyer and 
Kremsner, 1996). Thus OvL3.C1 may be involved in 
resistance mechanisms in onchocerciasis. Higher levels 
of IgG4 in putatively immune people against an antigen 
as found for OvL3.C1 in Ecuador is uncommon (Kwan-
Lim et al., 1990). The IgG4 in patients from Cameroon 
and putatively immune people from Ecuador may be such 
as to block IgE induced allergy, implicated in onchocercal 
pathogenesis (Ottessen, 1995). Contrary to findings in 
Cameroonian forest foci, putatively immune subjects from 
Ecuador had significantly higher IgG4 responses against 
the recombinant protein (Figure 6d). These differences in 
response   between   the  different  onchocerciasis  zones  




may be as a result of differences in genetic factors 
reported to influence immune responses to filarial 
infections (Kwan-Lim and Maizels, 1990; Abraham and 
Greives, 1990).  
This study isolated and identified OvL3.C1 as a 
dominant antigen in onchocerciasis with epitopes that 
may be involved in immunity against O. volvulus. 
Presence of native OvL3.C1 proteins in microfilariel and 
adults followed by reactivity of the recombinant protein 
with patient sera indicate that the antigen has a relevant 
role in onchocercisis.  We therefore envisage 
characterising the native variants of the protein to further 
establish its association to immune protective or 
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